Several studies have indicated that genetic or pharmacological inhibition of mTOR can rescue defects associated with severe mitochondrial disease in yeast (Schleit et al., 2013), worms (Peng et al., 2015), fruit flies (Wang et al., 2016), and mice (Johnson et al., 2013b, 2015b). This evidence concerns the gene MTOR and mitochondrial disease.